Seeking Alpha

Mylan (MYL) says it will launch sales of its generic version of Lipitor in France, Belgium, the...

Mylan (MYL) says it will launch sales of its generic version of Lipitor in France, Belgium, the U.K., the Netherlands and Ireland after winning regulatory approvals in each country. Atorvastatin Calcium serves as a generic version of Pfizer's Lipitor drug for the prevention of heart attacks.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|